Viewing Study NCT01390792


Ignite Creation Date: 2025-12-24 @ 3:33 PM
Ignite Modification Date: 2025-12-30 @ 8:23 PM
Study NCT ID: NCT01390792
Status: COMPLETED
Last Update Posted: 2017-05-16
First Post: 2011-07-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module